Autres langues GoodRx Holdings, Inc.

Actions

GDRX

US38246G1085

Temps réel estimé Cboe BZX Autres places de cotation 20:06:59 26/04/2024			Varia. 5j.	Varia. 1 janv.
7,175 ^USD	+1,34 %		+7,34 %	+7,18 %

10/04	GOODRX HOLDINGS, INC. : KeyBanc Capital Markets réajuste son opinion à la hausse	ZM
25/03	Les actions de GoodRx bondissent suite au relèvement de Wells Fargo et à l'augmentation de l'objectif de prix	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GDRX	25/04
GDRX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that GoodRx Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit	25/04
GDRX Bronstein, Gewirtz & Grossman LLC Announces that GoodRx Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!	25/04
GoodRx Announces Date for 2024 Investor Day	24/04
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GoodRx	24/04
GDRX Alert: Rosen, Skilled Investor Counsel, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GDRX	23/04
GDRX Kessler Topaz Meltzer & Check, LLP Files A Securities Fraud Class Action Lawsuit Against GoodRX Holdings, Inc. And Encourages Investors With Losses To Contact The Firm	22/04
GoodRx Announces Date for First Quarter 2024 Earnings Release and Conference Call	11/04
North American Morning Briefing : Stock Futures -2-	11/04
North American Morning Briefing : Traders Await -2-	10/04
North American Morning Briefing : Markets Steady -2-	26/03
GoodRx Shares Jump Following Wells Fargo Upgrade, Price Target Boost	25/03
Top Premarket Gainers	25/03
GoodRx Interim CEO Extends Commitment to Company	14/03
North American Morning Briefing : Stock Futures -2-	04/03
GoodRx Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/02
GoodRx Q4 Adjusted Earnings, Revenue Gain; Sets Q1, 2024 Revenue Outlook; Approves $450 Million Share Buyback Plan	29/02
Earnings Flash (GDRX) GOODRX HOLDINGS Reports Q4 Revenue $196.6M, vs. Street Est of $195.9M	29/02
Earnings Flash (GDRX) GOODRX HOLDINGS Reports Q4 EPS $0.08, vs. Street Est of $0.07	29/02
North American Morning Briefing : Fed's Preferred -2-	29/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues GoodRx Holdings, Inc.

Actions

GDRX

US38246G1085

Autres langues

Filtres